The European Commission has accelerated the timeline for the 2027 Horizon Europe Cluster 1 Health calls, bringing the first major deadline forward to 17 February 2027. For research organisations, universities, hospitals, SMEs, industry players, patient organisations and public authorities, this means there is significantly less time available to build consortia, refine concepts and prepare competitive proposals. Spinverse health domain experts are ready to support your project.
With over €600 million expected to be available across the 2027 Health work programme and topics covering disease prevention, innovative therapeutics, climate and health, diagnostics, AI, personalised medicine, healthcare interventions and advanced medical technologies, the upcoming calls present substantial opportunities for organisations seeking EU funding.
Some interesting one-stage calls
Single-stage calls with deadline on the 17th Feb 2027 include 11 calls. Find all the details on the EU Funding & Tenders portal.
HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicals /-> EU Funding & Tenders Portal
HORIZON-HLTH-2027-01-DISEASE-08 Development of innovative antimicrobials against pathogens resistant to antimicrobials -> EU Funding & Tenders Portal
HORIZON-HLTH-2027-01-DISEASE-07 Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses -> EU Funding & Tenders Portal
HORIZON-HLTH-2027-01-DISEASE-05 Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential -> EU Funding & Tenders Portal
2-stage calls with stage 1 deadline on 17th Feb 2027
Find these calls on the EU Funding & Tenders Portal.
HORIZON-HLTH-2027-02-DISEASE-14-two-stage:
Clinical trials for advancing innovative interventions for neurodegenerative
diseases -> EU Funding & Tenders Portal
HORIZON-HLTH-2027-02-IND-02-two-stage Portable and versatile Point-of-care diagnostics -> EU Funding & Tenders Portal
HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases -> EU Funding & Tenders Portal
HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases -> EU Funding & Tenders Portal
The time to act is now
Successful applicants will be those that start early, secure the right partners and develop a convincing impact-driven proposal well before the final submission deadline.
Whether you are looking to coordinate a project or join a consortium, Spinverse can help transform a promising idea into a competitive Horizon Europe proposal. Our experienced health domain professionals can provide your project with guidance in consortium building, proposal development, budgeting, impact planning and submission management.
Are you interested in discussing the opportunities offered by Horizon Europe’s Health Cluster 2027? Now is the ideal time to start shaping your project and consortium for the February deadline.
How can Spinverse help you succeed?
If your research is relevant to any of the areas mentioned above, please do not hesitate to contact Spinverse. We have strong competencies within cancer mission focus areas and successfully funded projects for our customers. We understand your needs and can provide you with
- Guidance in ideation & focus of the project scope to fit the call needs
- Co-ideation of project concept with consortium partners
- Support in finding new partners with the right expertise to form the consortium
- Advise throughout the innovation value chain with call-specific details to enrich the value of the proposal
- Help with budgeting
- Help prepare a winning funding proposal
- Securing your success in funding proposal.
More information on the calls: Calls for proposals | EU Funding & Tenders Portal
Are you planning to accelerate your health technology innovation with Horizon Europe's Health Cluster funding? The next calls are closing on 17 February 2027 - get in touch with our funding experts today!
Rohit Sood
Senior Director, Health Technologies,
Ph.D. MBA, Adjunct Prof. (Medicinal Biochem.)
rohit.sood@spinverse.com
+358 50 530 28639